Ruthenium(II) complexes coordinated to graphitic carbon nitride: Oxygen self-sufficient photosensitizers which produce multiple ROS for photodynamic therapy in hypoxia.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34391019.
- Also identified by DOI 10.1016/j.biomaterials.2021.121064.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The photodynamic therapy (PDT) of cancer is limited by tumor hypoxia as PDT efficiency depends on O<sub>2</sub> concentration. A novel oxygen self-sufficient photosensitizer (Ru-g-C<sub>3</sub>N<sub>4</sub>) was therefore designed and synthesized via a facile one-pot method in order to overcome tumor hypoxia-induced PDT resistance. The photosensitizer is based on [Ru(bpy)<sub>2</sub>]<sup>2+</sup> coordinated to g-C<sub>3</sub>N<sub>4</sub> nanosheets by Ru-N bonding. Compared to pure g-C<sub>3</sub>N<sub>4</sub>, the resulting nanosheets exhibit increased water solubility, stronger visible light absorption, and enhanced biocompatibility. Once Ru-g-C<sub>3</sub>N<sub>4</sub> is taken up by hypoxic tumor cells and exposed to visible light, the nanosheets not only catalyze the decomposition of H<sub>2</sub>O<sub>2</sub> and H<sub>2</sub>O to generate O<sub>2</sub>, but also catalyze H<sub>2</sub>O<sub>2</sub> and O<sub>2</sub> concurrently to produce multiple ROS (<sup>•</sup>OH, <sup>•</sup>O<sub>2</sub><sup>-</sup>, and <sup>1</sup>O<sub>2</sub>). In addition, Ru-g-C<sub>3</sub>N<sub>4</sub> affords luminescence imaging, while continuously generating O<sub>2</sub> to alleviate hypoxia greatly improving PDT efficacy. To the best of our knowledge, this oxygen self-sufficient photosensitizer produced via grafting a metal complex onto g-C<sub>3</sub>N<sub>4</sub> is the first of its type to be reported.
Medical subject headings
- Photochemotherapy
- Ruthenium